Mumbai: On the ETHealthworld Fertility Conclave, a forward-looking panel dialogue on “Egg Meets Algorithm – The Subsequent Frontier in Reproductive Well being” introduced collectively clinicians, embryologists and genomics consultants to look at how synthetic intelligence (AI) is reshaping fertility care. The dialog underscored a crucial shift: from subjective, trial-and-error IVF practices to a extra data-driven, predictive and personalised strategy.
Setting the tone, Dr Nikita Lad Patel, Advisor IVF Specialist, Apollo Fertility, highlighted how AI is starting to decode patterns in gametes and embryos that stay invisible to the human eye. By leveraging superior analytics, clinicians are more and more capable of refine embryo choice and enhance outcomes whereas probably decreasing the necessity for repeated IVF cycles. Nonetheless, she famous that AI at present represents “two sides of a coin”—whereas it holds promise for bettering being pregnant possibilities and medical precision, its real-world utility remains to be evolving.
Dr Kshitiz Murdia, Co-Founder and CEO of Indira IVF, supplied a practical perspective, noting that whereas AI has not but dramatically improved being pregnant charges, its most quick impression lies in enhancing consistency and decreasing variability in medical apply throughout India. In a rustic with vast disparities in experience and infrastructure, AI-powered medical assist programs may help standardise decision-making throughout clinics and practitioners.
He emphasised that IVF generates huge quantities of information from affected person demographics and hormonal profiles to embryo improvement and switch methods. Integrating this knowledge into unified platforms and making use of AI-driven analytics might unlock the following massive leap in fertility care. “It’s not nearly selecting the right embryo or marginal beneficial properties in being pregnant charges,” he defined, including that the actual worth lies in delivering constant, high-quality care throughout geographies and clinicians.
On the similar time, Dr Murdia cautioned in opposition to over-reliance on algorithms. Present AI instruments, he famous, can typically misclassify embryos, significantly in complicated instances. This reinforces the necessity for a “human-in-the-loop” strategy, the place embryologists and clinicians stay central to decision-making, with AI serving as an assistive software quite than a substitute.
Increasing the dialogue to high-risk pregnancies, Dr Sonal Kumta, Senior Advisor Obstetrician and Gynecologist, Fortis Hospital, Mulund, highlighted the potential of data-driven insights in managing sufferers with dangerous obstetric historical past, together with recurrent miscarriages and unexplained being pregnant losses. Such instances, she stated, are sometimes emotionally and clinically difficult because of the lack of clear diagnostic solutions.
She believes AI and huge datasets might assist establish underlying patterns whether or not hormonal, genetic or thrombotic enabling extra exact threat evaluation and therapy planning. From choices on interventions like cervical cerclage to optimising foetal monitoring, data-backed insights can present larger readability and confidence in managing these high-stakes pregnancies. Nonetheless, she confused that medical experience stays indispensable, with AI appearing as a supportive layer to strengthen evidence-based care.
The function of AI in reproductive genetics was one other key focus space. Shaiket Deb, Director – Uncommon Ailments and Reproductive Well being, Strand Life Sciences, identified that the majority current genetic classifications are based mostly on Western datasets, which can not absolutely apply to the Indian inhabitants. With the combination of AI and regionally generated knowledge, researchers are actually starting to establish population-specific genetic variations and their medical relevance.
AI can also be accelerating the interpretation of genetic knowledge, decreasing turnaround occasions for variant evaluation from weeks to only a few days. By streamlining the filtering and prioritisation of genetic findings, it’s serving to clinicians make quicker and extra knowledgeable choices, whereas additionally bringing down prices. On the similar time, Deb cautioned in opposition to indiscriminate testing, noting that not each affected person requires intensive genetic screening, and AI may help tailor testing methods extra appropriately.
Collectively, the panel converged on a transparent message: AI isn’t a substitute for human experience however a strong enabler. Its true potential lies in augmenting medical judgment, bettering standardisation, and unlocking insights from complicated datasets that have been beforehand underutilised.
As fertility care turns into more and more data-intensive, the intersection of biology and expertise the place the “egg meets algorithm” is poised to redefine reproductive medication. Whereas the journey remains to be in its early phases, the combination of AI guarantees a future the place fertility therapy isn’t solely extra exact and personalised, but in addition extra equitable and accessible throughout numerous affected person populations.
